This half-day session will introduce participants to the new GastroPlus® 10.2 (GPX.2™) platform and its application to drug development scenarios. Leveraging mechanistic physiologically based pharmacokinetic (PBPK) and biopharmaceutics modeling (PBBM) approaches, the session will highlight how the integrated AssessmentsPlus™ and Distribution Dashboard, alongside Orchestrator can be applied to accelerate baseline model development, and how the integrated P-PSD™ module can be used to predict formulation outcomes. Through live demonstrations and guided exercises, attendees will explore how GPX.2 enables faster, more robust decision-making for clinical pharmacology and biopharmaceutics applications.

Who should attend?

This session is designed for students, scientists and regulatory professionals working in formulation development, clinical pharmacology, biopharmaceutics, and modeling & simulation who are looking to harness GPX.2 innovations to accelerate development timelines, strengthen predictive accuracy, and reduce reliance on costly clinical studies. *Light refreshments provided

Instructors:

• Maxime Le Merdy – Director, Scientific Product Enablement, Product Enablement
• Daniela Silva – Sr. Scientific Product Specialist, Product Enablement
• Fiona Plait – Scientific Product Specialist, Product Enablement